Expression of aldehyde dehydrogenase 1 in breast cancer and its clinical significance

Tumor

Volumn 29, Issue 7, 2009, Pages 663-667

  Zhou, Ling ^a   Yu, Pei ^a   Wang, Jian Feng ^a   Song, Ke Ying ^a   Jiang, Ai Fang ^b   Xu, Hong ^b   Li, Ke ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Aldehyde dehydrogenase 1; Breast neoplasms; Immunohistochemistry; Stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RESISTANCE; CANCER STAGING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; STEM CELL; SURVIVAL RATE; TUMOR VOLUME;

EID: 77953437176     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2009.07.013     Document Type: Article

References (13)

1. ZHANG M, ROSEN J. Stem cells in the etiology and treatment of cancer[J]. Cur Opin Cenet Dev, 2006,16(1):60-64. (Pubitemid 43089613)
2. AL-HAJJ M, WICHA M S, BENITO-HERNANDEZ A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci U S A, 2003,100(7):3983-3988.
3. Chinese source
4. Chinese source
5. BALICKI D. Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1[J]. Cell Stem Cell, 2007,1(5):485-487.
6. HESS D A, MEYERROSE T E, WIRTHLIN L, et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity[J]. Blood, 2004,104(6):1648-1655.
7. CHUTE J P, MURAMOTO G G, WHITESIDES J, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells[J]. Proc Natl Acad Sci U S A, 2006,103(31):11707-111702
8. FALLON P, GENTRY T, BALLER A E, et al. Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation[J]. Br J Haematol, 2003,122(1):99-108.
9. GINESTIER C, HUR M H, CHARAFE-JAUFFRET E, et al. ALDHI is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J]. Cell Stem Cell, 2007,1(5):555-567.
10. MOREB J S, SCHWEDER M, SURESH A, et al. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide[J]. Cancer Gene Ther, 1992,3(1):24-30.
11. ZHOU S, SCHUETZ J D, BUNTING K D, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype[J]. Nat Med, 2001,7(9):1028-1034.
12. SELL S. Stem cell origin of cancer and differentiation therapy[J]. Crit Rev Oncol Hematol, 2004,51(1):1-28. (Pubitemid 38781748)
13. + T-cell defined tumor antigen in squamous cell carcinoma of the head and neck[J]. Cancer Res, 2007,67(21):10538-10545.